Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Kidney Disease Investigation(Electronic Edition) ›› 2020, Vol. 09 ›› Issue (06): 253-259. doi: 10.3877/cma.j.issn.2095-3216.2020.06.003

Special Issue:

• Review • Previous Articles     Next Articles

Effects of different renal replacement therapies on cognitive impairment in patients with end-stage renal disease

Mingshuai Li1, Nan Wang2,()   

  1. 1. The First Affiliated Hospital of Dalian Medical University, Dalian 116011; Graduate School of Dalian Medical University, Dalian 116044; Liaoning Province, China
    2. The First Affiliated Hospital of Dalian Medical University, Dalian 116011
  • Received:2020-08-24 Online:2020-12-28 Published:2020-12-28
  • Contact: Nan Wang
  • About author:
    Corresponding author: Wang Nan, Email:

Abstract:

With the improvement of renal replacement therapy technology including hemodialysis, peritoneal dialysis and kidney transplantation, the survival rate of patients with end-stage renal disease (ESRD) has been significantly prolonged, but the quality of life is significantly lower than that of healthy people. Cognitive impairment is widespread in patients with chronic kidney disease (CKD), especially in ESRD patients, and is one of the important factors affecting the quality of life of the patients. This article reviewed the epidemiology, pathogenesis, and risk factors of cognitive impairment in ESRD patients, focusing on the analysis of the effects and mechanisms of different renal replacement therapies on cognitive impairment.

Key words: End-stage renal disease, Cognitive impairment, Hemodialysis, Peritoneal dialysis, Kidney transplantation

京ICP 备07035254号-35
Copyright © Chinese Journal of Kidney Disease Investigation(Electronic Edition), All Rights Reserved.
Tel: 010-66937011 E-mail: zhsbyj@126.com
Powered by Beijing Magtech Co. Ltd